Personalis

Home » Personalis

IPO

Personalis

Biotechnology

We are a growing cancer genomics company transforming the development of next-generation therapies by providing more comprehensive molecular data about each patient’s cancer and immune response.

Symbol

PSNL

Price Range
$14.00 - $16.00

Final Shares
6,666,667

Anticipated Date
June 20, 2019

Underwriters
MORGAN STANLEY & CO. LLC,OPPENHEIMER & CO. INC.

This offering is no longer available

To view the prospectus for Personalis IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253